Protocol for efficient generation of human artery and vein endothelial cells from pluripotent stem cells

Blood vessels permeate all organs and execute myriad roles in health and disease. Here, we present a protocol to efficiently generate human artery and vein endothelial cells (ECs) from pluripotent stem cells within 3-4 days of differentiation. We delineate how to seed human pluripotent stem cells and sequentially differentiate them into primitive streak, lateral mesoderm, and either artery or vein ECs. We differentiate stem cells in defined, serum-free culture media in monolayers, without feeder cells or genetic manipulations. For complete details on the use and execution of this protocol, please refer to Ang et al. <sup>1</sup>.

Authors

Institutions

Publication Details

Journal
STAR Protocols
Published
2024-12-18
DOI
https://doi.org/10.1016/j.xpro.2024.103494
Citations
6
Primary Topic
Pluripotent Stem Cells Research
Type
article
Field-Weighted Citation Impact
1.40

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Protocol for efficient generation of human artery and vein endothelial cells from pluripotent stem cells

Sherry Li Zheng, Sawan Kumar Jha, Kyle M. Loh, Christine Cheung et al.
6 citations
STAR Protocols
Pluripotent Stem Cells Research
1.40
article

Protocol for efficient generation of human artery and vein endothelial cells from pluripotent stem cells

Sherry Li Zheng, Sawan Kumar Jha, Kyle M. Loh, Christine Cheung, Alana Nguyen, Kevin J. Liu, Lay Teng Ang, Edda Spiekerkoetter, Vanessa Kristina Wazny, Kristy Red‐Horse, Qingqing Yin, Angela Chen, Yue Qi, Faith-Masong Njunkeng, Zhainib A Amir-Ugokwe
article en
6 citations

Abstract

Blood vessels permeate all organs and execute myriad roles in health and disease. Here, we present a protocol to efficiently generate human artery and vein endothelial cells (ECs) from pluripotent stem cells within 3-4 days of differentiation. We delineate how to seed human pluripotent stem cells and sequentially differentiate them into primitive streak, lateral mesoderm, and either artery or vein ECs. We differentiate stem cells in defined, serum-free culture media in monolayers, without feeder cells or genetic manipulations. For complete details on the use and execution of this protocol, please refer to Ang et al. <sup>1</sup>.

STAR ProtocolsVol. 6(1)
Howard Hughes Medical Institute (US), Nanyang Technological University (SG), California Institute for Regenerative Medicine (US), Pulmonary and Allergy Associates (US), Stanford Medicine (US), Institute of Molecular and Cell Biology (SG), Stanford University (US)
National Science Foundation, Howard Hughes Medical Institute, California Institute for Regenerative Medicine, Stanford Diabetes Research Center, Additional Ventures, National Institutes of Health, Advanced Research Projects Agency, Ludwig Center at Harvard, Lee Kong Chian School of Medicine, Nanyang Technological University, Stanford Maternal and Child Health Research Institute
Zero hunger
Openalex Percentile: Top 18%
Pluripotent Stem Cells Research
1.40
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.